Matthew T Stier

7PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
SAP loss limits anti-insulin atypical B cell activation and pro-inflammatory CD8 T cells despite preserved Tfh responses to protect against type 1 diabetes.

|Jun 12, 2026
Critical illness expands a transcriptionally distinct hypometabolic CD8+ T effector program associated with respiratory failure and mortality.

|Jan 16, 2026
Metabolic adaptations rewire CD4+ T cells in a subset-specific manner in human critical illness with and without sepsis.

Matthew T Stier, Allison E Sewell, Erin L Mwizerwa

|Jan 03, 2026
Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.

Mark Rusznak, Shinji Toki, Yajing Hao

|Feb 20, 2025
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis.

Matthew T Stier, Allison E Sewell, Erin L Mwizerwa

|Mar 31, 2023
Immune characterization of a xenogeneic human lung cross-circulation support system.

Wei K Wu, Matthew T Stier, John W Stokes

Pageof 2

Frequent Collaborators

3 joint publications

Casey M Nichols

3 joint publications

Lorraine B Ware

3 joint publications

Jeffrey C Rathmell

3 joint publications

Erin M Wilfong